Evolution of hepatitis C virus hypervariable region 1 in chronically infected children

Virus Research

Volumn 167, Issue 2, 2012, Pages 380-384

  Jackowiak, Paulina ^a   Kowala Piaskowska, Arleta ^b   Figlerowicz, Magdalena ^b   Alejska, Magdalena ^a   Malinowska, Nelli ^a   Figlerowicz, Marek ^a,c  

^a INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c POZNAN UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Chronic hepatitis C; Evolution; Hypervariable region 1; Pediatric patients; Quasispecies

Indexed keywords

VIRUS RNA;

ADOLESCENT; AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; GENETIC CONSERVATION; GENETIC VARIABILITY; HEPATITIS C; HUMAN; PHYLOGENY; PRIORITY JOURNAL; SCHOOL CHILD; SIGNAL TRANSDUCTION; VERTICAL TRANSMISSION; VIRUS ISOLATION;

ADOLESCENT; CHILD; CLUSTER ANALYSIS; EVOLUTION, MOLECULAR; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS;

HEPATITIS C VIRUS;

EID: 84863878830     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.05.005     Document Type: Article

References (23)

1. Bankwitz D., Steinmann E., Bitzegeio J., Ciesek S., Friesland M., Herrmann E., Zeisel M.B., Baumert T.F., Keck Z.Y., Foung S.K., Pecheur E.I., Pietschmann T. Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes. Journal of Virology 2010, 84(11):5751-5763.
2. Bull R.A., Luciani F., McElroy K., Gaudieri S., Pham S.T., Chopra A., Cameron B., Maher L., Dore G.J., White P.A., Lloyd A.R. Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. Public Library of Science Pathogens 2011, 7(9):e1002243.
3. Callens N., Ciczora Y., Bartosch B., Vu-Dac N., Cosset F.L., Pawlotsky J.M., Penin F., Dubuisson J. Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein E2 contribute to virus entry. Journal of Virology 2005, 79(24):15331-15341.
4. Canobio S., Guilbert C.M., Troesch M., Samson J., Lemay M., Pelletier V.A., Bernard-Bonnin A.C., Kozielski R., Lapointe N., Martin S.R., Soudeyns H. Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1. Journal of Clinical Microbiology 2004, 42(9):4365-4369.
5. Castellano G. The natural history of hepatitis C virus infection. Nephrology, Dialysis, Transplantation 2000, 15(Suppl. 8):19-23.
6. Domingo E., Gomez J. Quasispecies and its impact on viral hepatitis. Virus Research 2007, 127(2):131-150.
7. Farci P., Quinti I., Farci S., Alter H.J., Strazzera R., Palomba E., Coiana A., Cao D., Casadei A.M., Ledda R., Iorio R., Vegnente A., Diaz G., Tovo P.A. Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(22):8475-8480.
8. Figlerowicz M., Alejska M., Kurzyńska-Kokorniak A., Figlerowicz M. Genetic variability: the key problem in the prevention and therapy of RNA-based virus infections. Medicinal Research Reviews 2003, 23(4):488-518.
9. Figlerowicz M., Formanowicz P., Kedziora P., Alejska M., Jackowiak P., Blazewicz J., Sluzewski W., Figlerowicz M. The clinical consequences of changes occurring in HCV population during the first weeks of chronic hepatitis C treatment with interferon and ribavirin. Przeglad Epidemiologiczny 2005, 59(2):581-590.
10. Figlerowicz M., Jackowiak P., Formanowicz P., Kedziora P., Alejska M., Malinowska N., Blazewicz J., Figlerowicz M. Hepatitis C virus quasispecies in chronically infected children subjected to interferon-ribavirin therapy. Archives of Virology 2010, 155(12):1977-1987.
11. Figlerowicz M., Słuzewski W., Kowala-Piaskowska A., Mozer-Lisewska I. Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C. European Journal of Pediatrics 2004, 163(4-5):265-267.
12. Gerotto M., Resti M., Dal Pero F., Migliorato I., Alberti A., Bortolotti F. Evolution of hepatitis C virus quasispecies in children with chronic hepatitis C. Infection 2006, 34(2):62-65.
13. Gismondi M.I., Becker P.D., Diaz Carrasco J.M., Guzman C.A., Campos R.H., Preciado M.V. Evolution of hepatitis C virus hypervariable region 1 in immunocompetent children born to HCV-infected mothers. Journal of Viral Hepatitis 2009, 16(5):332-339.
14. Jonas M.M. Children with hepatitis C. Hepatology 2002, 36(5 (Suppl. 1)):S173-S178.
15. Kaplan M., Gawrieh S., Cotler S.J., Jensen D.M. Neutralizing antibodies in hepatitis C virus infection: a review of immunological and clinical characteristics. Gastroenterology 2003, 125(2):597-604.
16. Kuiken C., Yusim K., Boykin L., Richardson R. The Los Alamos hepatitis C sequence database. Bioinformatics 2005, 21(3):379-384.
17. Mas A., Ulloa E., Bruguera M., Furcic I., Garriga D., Fabregas S., Andreu D., Saiz J.C., Diez J. Hepatitis C virus population analysis of a single-source nosocomial outbreak reveals an inverse correlation between viral load and quasispecies complexity. Journal of General Virology 2004, 85(Pt 12):3619-3626.
18. McAllister J., Casino C., Davidson F., Power J., Lawlor E., Yap P.L., Simmonds P., Smith D.B. Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort. Journal of Virology 1998, 72(6):4893-4905.
19. Penin F., Combet C., Germanidis G., Frainais P.O., Deleage G., Pawlotsky J.M. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. Journal of Virology 2001, 75(12):5703-5710.
20. Quesnel-Vallieres M., Lemay M., Lapointe N., Martin S.R., Soudeyns H. HCV quasispecies evolution during treatment with interferon alfa-2b and ribavirin in two children coinfected with HCV and HIV-1. Journal of Clinical Virology 2008, 43(2):236-240.
21. Ramachandran S., Campo D.S., Dimitrova Z.E., Xia G.L., Purdy M.A., Khudyakov Y.E. Temporal variations in the hepatitis C virus intrahost population during chronic infection. Journal of Virology 2011, 85(13):6369-6380.
22. Roccasecca R., Ansuini H., Vitelli A., Meola A., Scarselli E., Acali S., Pezzanera M., Ercole B.B., McKeating J., Yagnik A., Lahm A., Tramontano A., Cortese R., Nicosia A. Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2. Journal of Virology 2003, 77(3):1856-1867.
23. Wang G.P., Sherrill-Mix S.A., Chang K.M., Quince C., Bushman F.D. Hepatitis C virus transmission bottlenecks analyzed by deep sequencing. Journal of Virology 2010, 84(12):6218-6228.